GES

Gemoscan Canada, Inc. ("Gemoscan" or the "Corporation") - (TSX VENTURE:GES)
(MUN:1GE) wishes to announce that it has entered into an unsecured loan
agreement with an arm's length party (the "Lender"). The Lender has provided the
Corporation a $150,000 loan (the "Loan"), bearing interest at a rate of 8% per
annum and which matures on August 31, 2013. Additionally, in connection with the
Loan, the Lender will receive a bonus 129,032 Class A Shares (the "Shares") in
the capital of the Corporation at a price of $0.2325 per Share. All Shares are
subject to a statutory four month plus one day hold period from August 31, 2012.


Gemoscan also wishes to announce that it has entered into an additional
unsecured loan agreement with an arm's length party (the "Holder"). The Holder
has provided the Corporation a $175,000 loan.


ABOUT GEMOSCAN CANADA, INC. 

Gemoscan is an industry leader in food intolerance management and maintains a
first-to-market position with Canada wide distribution through select retail
partners. Founded in 2003, using its proprietary patented technology; Gemoscan
develops, owns and markets comprehensive food sensitivity and dietary management
solutions for consumers, including the HEMOCODE(TM) Food Intolerance System, a
personalized naturopathic nutritional program that promotes well-being. Gemoscan
is the first and only provider to commercialize a food intolerance management
solution directly to consumers in partnership with retailers, and today offers
the most comprehensive services available.


Gemoscan Canada, Inc. trades its shares on the Toronto Venture Exchange (TSX-V)
under the symbol GES and is quoted on the Munich, Frankfurt and Stuttgart Stock
Exchanges under the symbol 1GE.


Forward-Looking Information 

This news release contains certain "forward-looking information". All
statements, other than statements of historical fact that address activities,
events or developments that Gemoscan believes, expects or anticipates will or
may occur in the future. These forward-looking statements reflect the current
expectations or beliefs of Gemoscan based on information currently available to
Gemoscan. Forward-looking statements are subject to a number of significant
risks and uncertainties and other factors that may cause the actual results of
Gemoscan to differ materially from those discussed in the forward-looking
statements, and even if such actual results are realized or substantially
realized, there can be no assurance that they will have the expected
consequences to, or effects on Gemoscan. Any forward-looking statement speaks
only as of the date on which it is made and, except as may be required by
applicable securities laws, Gemoscan disclaims any intent or obligation to
update any forward-looking statement, whether as a result of new information,
future events or results or otherwise. Although Gemoscan believes that the
assumptions inherent in the forward-looking statements are reasonable,
forward-looking statements are not guarantees of future performance and
accordingly undue reliance should not be put on such statements due to the
inherent uncertainty therein.

Gemoscan Canada, Inc. (TSXV:GES)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Gemoscan Canada, Inc. (TSXV:GES)
Historical Stock Chart
Von Jun 2023 bis Jun 2024